Academic Year: | 2018/9 |
Owning Department/School: | Department of Pharmacy & Pharmacology |
Credits: | 6 [equivalent to 12 CATS credits] |
Notional Study Hours: | 120 |
Level: | Masters UG & PG (FHEQ level 7) |
Period: |
- Modular (no specific semester)
|
Assessment Summary: | CW 100%, OT 0% |
CW 80%, MC 20%, OT 0% |
Assessment Detail: |
- Assessment Group A: Medicines Optimisation Tool (ass't grp A PhIF Bath) (CW 60%)
- Medicines Optimisation Tool (CW 60%)
- Assessment Group A: CARE Tool (ass't grp A PhIF Bath) (CW 20%)
- CARE Tool (CW 20%)
- Assessment Group A: pOSA (ass't grp A PhIF Bath) (MC 20%)
- Online Portfolio Task (CW 20%)
- Assessment Group A: Workshop Attendance (ass't grp A PhIF Bath) (OT 0%)
- Workshop Attendance (OT 0%)
- Assessment Group B: Medicines Optimisation Tool (ass't grp B PhIF London) (CW 60%)
- Assessment Group B: CARE Tool (ass't grp B PhIF London) (CW 20%)
- Assessment Group B: pOSA (ass't grp B PhIF London) (MC 20%)
- Assessment Group B: Workshop Attendance (ass't grp B PhIF London) (OT 0%)
- Assessment Group C: Medicines Optimisation Tool (ass't grp C PhIF South) (CW 60%)
- Assessment Group C: CARE Tool (ass't grp C PhIF South) (CW 20%)
- Assessment Group C: pOSA (ass't grp C PhIF South) (MC 20%)
- Assessment Group C: Workshop Attendance (ass't grp C PhIF South) (OT 0%)
- Assessment Group D: Medicines Optimisation Tool (ass't grp D Non-PhIF) (CW 60%)
- Assessment Group D: CARE Tool (ass't grp D Non-PhIF) (CW 20%)
- Assessment Group D: pOSA (ass't grp D Non-PhIF) (MC 20%)
- Assessment Group D: Workshop Attendance (ass't grp D Non-PhIF) (OT 0%)
|
Supplementary Assessment: |
- Like-for-like reassessment (where allowed by programme regulations)
|
Requisites: |
In taking this module you cannot take PA50186
Some overlap exists with learning outcomes and content in PA50202 and PA50221. You must not cover Stroke or Renal Disease as a therapeutic area for this unit if you have already used these areas in assessments in PA50202 or PA50221.
|
Description:
| Aims: To update underpinning knowledge of a range of long term conditions and therapeutics enabling pharmacists to support patients in the self-management of their conditions, through optimising medicines use.
Learning Outcomes: On successful completion of this unit students will be able to:
1. Critically discuss the pharmacist's role in managing long term conditions. (Medicines Optimisation Tool [MOT])
2. Critically evaluate the evidence base for the management of cardiovascular disease, specifically hypertension, atrial fibrillation, stroke, transient ischaemic attack and chronic kidney disease (CKD) (intellectual skill) (MOT)
3. Analyse and critically reflect on your role in reviewing medication and monitoring their safety and effectiveness in patients with the above conditions. (knowledge and understanding) (MOT, Clinical Activity Reflective Exercise [CARE], portfolio task)
4. Explain the pathophysiology, symptoms and patient monitoring factors in the above conditions. (MOT, portfolio task)
5. Apply good communication and patient centred consultation skills to enhance the patient experience. ( Formative Work Based Assessment [WBA] and MOT)
6. Apply commonly used clinical skills relevant to the above conditions i.e. blood pressure and pulse measurement. (taught / facilitated)
7. Safely review medication and optimise medicines use in patients with the above conditions.(MOT)
Skills:
* Planning & organisation
* Basic clinical examination skills
* Consultation skills
* Study skills
* Handling information
* communication skills
* Working with others
* Problem solving
* Scientific and practical skills
* Improving learning and performance
* Reflective practice
* Information & communication technology
Content: Approaches to managing long term conditions
Hypertension
Atrial Fibrillation
Stroke and TIA
CKD.
|
|
Programme availability: |
PA50336 is Optional on the following programmes:
Department of Pharmacy & Pharmacology
- TSPA-ADT16 : Modular Programme in Advanced and Specialist Practice
- TSPA-ADM16 : MSc Advanced and Specialist Healthcare Practice
- TSPA-ADM10 : MSc Clinical Pharmacy Practice (Primary Care)
- TSPA-ADM17 : MSc Clinical Pharmacy Practice (Primary Care)
- TSPA-ADM12 : MSc Prescribing & Therapeutics
- TSPA-ADM19 : MSc Prescribing & Therapeutics
- TSPA-ADC16 : PG Cert Advanced and Specialist Healthcare Practice
- TSPA-ADC12 : PG Cert Clinical Pharmacy Practice (Primary Care)
- TSPA-ADC17 : PG Cert Clinical Pharmacy Practice (Primary Care)
- TSPA-ADC15 : PG Cert Prescribing & Therapeutics
- TSPA-ADC19 : PG Cert Prescribing & Therapeutics
- TSPA-ADL16 : PG Dip Advanced and Specialist Healthcare Practice
- TSPA-ADL11 : PG Dip Clinical Pharmacy Practice (Primary Care)
- TSPA-ADL17 : PG Dip Clinical Pharmacy Practice (Primary Care)
- TSPA-ADL12 : PG Dip Prescribing & Therapeutics
- TSPA-ADL19 : PG Dip Prescribing & Therapeutics
|